FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059844041> ?p ?o ?g. }

• W2059844041 endingPage "S7" @default.
• W2059844041 startingPage "S2" @default.
• W2059844041 abstract "Isotretinoin is most effective for patients with acne who fail to respond to other forms of treatment; virtually all patients respond to isotretinoin, 0.5 to 1.0 mg/kg/day. As many as 61% of patients are cured after one course, but 39% require further isotretinoin (16%) or oral antibiotics (23%). The relapse rate can be reduced by the administration of the higher dose of 1 mg/kg/day (thus achieving a significant cumulative dose of >120 mg/kg), especially to young patients and men with truncal acne and more severe disease. About 85% require a 4-month course, but 15% require longer treatment, with some up to 10 months. There are several reasons for a slow response to treatment, including the presence of macrocomedones, ovarian dysfunction, and as-yet unknown factors. Macrocomedones can be treated with light cautery, ovarian dysfunction with hormonal therapies, and in those persons who have no obvious explanation for slow response, persistence with isotretinoin alone is required. Repeat courses of isotretinoin can also be given. Six years ago most patients treated with isotretinoin had severe acne (60%), but today most patients (60%) have therapy-resistant moderate acne. Isotretinoin is a consideration in such patients to reduce the physical and psychological effects of acne, particularly because there is no simple method to treat acne scars. Isotretinoin is most effective for patients with acne who fail to respond to other forms of treatment; virtually all patients respond to isotretinoin, 0.5 to 1.0 mg/kg/day. As many as 61% of patients are cured after one course, but 39% require further isotretinoin (16%) or oral antibiotics (23%). The relapse rate can be reduced by the administration of the higher dose of 1 mg/kg/day (thus achieving a significant cumulative dose of >120 mg/kg), especially to young patients and men with truncal acne and more severe disease. About 85% require a 4-month course, but 15% require longer treatment, with some up to 10 months. There are several reasons for a slow response to treatment, including the presence of macrocomedones, ovarian dysfunction, and as-yet unknown factors. Macrocomedones can be treated with light cautery, ovarian dysfunction with hormonal therapies, and in those persons who have no obvious explanation for slow response, persistence with isotretinoin alone is required. Repeat courses of isotretinoin can also be given. Six years ago most patients treated with isotretinoin had severe acne (60%), but today most patients (60%) have therapy-resistant moderate acne. Isotretinoin is a consideration in such patients to reduce the physical and psychological effects of acne, particularly because there is no simple method to treat acne scars." @default.
• W2059844041 created "2016-06-24" @default.
• W2059844041 creator A5058889545 @default.
• W2059844041 creator A5063266899 @default.
• W2059844041 date "1992-12-01" @default.
• W2059844041 modified "2023-10-17" @default.
• W2059844041 title "Guidelines for optimal use of isotretinoin in acne" @default.
• W2059844041 cites W1584295824 @default.
• W2059844041 cites W1973337644 @default.
• W2059844041 cites W1975931900 @default.
• W2059844041 cites W1978049949 @default.
• W2059844041 cites W1983745922 @default.
• W2059844041 cites W2004257274 @default.
• W2059844041 cites W2008802413 @default.
• W2059844041 cites W2012798003 @default.
• W2059844041 cites W2016739566 @default.
• W2059844041 cites W2017067817 @default.
• W2059844041 cites W2019160294 @default.
• W2059844041 cites W2019580446 @default.
• W2059844041 cites W2020601786 @default.
• W2059844041 cites W2021294869 @default.
• W2059844041 cites W2026971310 @default.
• W2059844041 cites W2043157381 @default.
• W2059844041 cites W2048568497 @default.
• W2059844041 cites W2065618985 @default.
• W2059844041 cites W2066435335 @default.
• W2059844041 cites W2066995212 @default.
• W2059844041 cites W2077388811 @default.
• W2059844041 cites W2092256426 @default.
• W2059844041 cites W2092740507 @default.
• W2059844041 cites W2103760238 @default.
• W2059844041 cites W2109674038 @default.
• W2059844041 cites W2122214761 @default.
• W2059844041 cites W2143737942 @default.
• W2059844041 cites W2144235412 @default.
• W2059844041 cites W4247508119 @default.
• W2059844041 doi "https://doi.org/10.1016/s0190-9622(08)80252-6" @default.
• W2059844041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1460120" @default.
• W2059844041 hasPublicationYear "1992" @default.
• W2059844041 type Work @default.
• W2059844041 sameAs 2059844041 @default.
• W2059844041 citedByCount "93" @default.
• W2059844041 countsByYear W20598440412012 @default.
• W2059844041 countsByYear W20598440412013 @default.
• W2059844041 countsByYear W20598440412014 @default.
• W2059844041 countsByYear W20598440412015 @default.
• W2059844041 countsByYear W20598440412016 @default.
• W2059844041 countsByYear W20598440412018 @default.
• W2059844041 countsByYear W20598440412019 @default.
• W2059844041 countsByYear W20598440412020 @default.
• W2059844041 countsByYear W20598440412021 @default.
• W2059844041 countsByYear W20598440412022 @default.
• W2059844041 countsByYear W20598440412023 @default.
• W2059844041 crossrefType "journal-article" @default.
• W2059844041 hasAuthorship W2059844041A5058889545 @default.
• W2059844041 hasAuthorship W2059844041A5063266899 @default.
• W2059844041 hasConcept C126322002 @default.
• W2059844041 hasConcept C16005928 @default.
• W2059844041 hasConcept C2776285725 @default.
• W2059844041 hasConcept C2777673923 @default.
• W2059844041 hasConcept C71924100 @default.
• W2059844041 hasConceptScore W2059844041C126322002 @default.
• W2059844041 hasConceptScore W2059844041C16005928 @default.
• W2059844041 hasConceptScore W2059844041C2776285725 @default.
• W2059844041 hasConceptScore W2059844041C2777673923 @default.
• W2059844041 hasConceptScore W2059844041C71924100 @default.
• W2059844041 hasIssue "6" @default.
• W2059844041 hasLocation W20598440411 @default.
• W2059844041 hasLocation W20598440412 @default.
• W2059844041 hasOpenAccess W2059844041 @default.
• W2059844041 hasPrimaryLocation W20598440411 @default.
• W2059844041 hasRelatedWork W1831466767 @default.
• W2059844041 hasRelatedWork W2027614408 @default.
• W2059844041 hasRelatedWork W2080436120 @default.
• W2059844041 hasRelatedWork W2091461711 @default.
• W2059844041 hasRelatedWork W2305922381 @default.
• W2059844041 hasRelatedWork W2563438566 @default.
• W2059844041 hasRelatedWork W2572390839 @default.
• W2059844041 hasRelatedWork W2789590115 @default.
• W2059844041 hasRelatedWork W2791757255 @default.
• W2059844041 hasRelatedWork W4385231871 @default.
• W2059844041 hasVolume "27" @default.
• W2059844041 isParatext "false" @default.
• W2059844041 isRetracted "false" @default.
• W2059844041 magId "2059844041" @default.
• W2059844041 workType "article" @default.